Further study exerted that CCDC6 was a predicted target of miR-19b-3p, and in vivo study displayed that miR-19b-3p/CCDC6 axis modulated EMT to promote intrahepatic cholangiocarcinoma development [46]. The gene discussed is CCDC6; the disease is intrahepatic cholangiocarcinoma.